H uman NK cells are large granular CD3
Ϫ CD16 ϩ CD56 ϩ lymphocytes that play an important role in the host immune response against tumors, virally infected cells, and bacterial infections (1) . They are able to initiate host responses without clonal expansion and, therefore, can function as part of the early or "innate" immune response to antigenic challenge. In addition to mediating cytotoxicity, NK cells play an important regulatory role in immune responses through production of cytokines (2) . IFN-␥ is one of the cytokines produced by activated NK cells. It is a potent activator of macrophages and is critical for the early control of many pathogenic organisms.
In recent years the therapeutic potential of cytokine-activated NK cells has been a major focus of cancer research. Cytokines such as IL-2, IL-15, IL-12, and IL-18 enhance NK cell function (cytotoxicity and IFN-␥ production) (3) (4) (5) (6) and, therefore, have tremendous potential as therapeutic agents for cancer treatment. Recent studies suggest that IL-15 may be a better candidate for immunotherapy of cancer patients or patients with HIV infection because it has the same effects on NK cell function as IL-2, but is much less toxic (7, 8) .
Although potentiating immune responses by cytokines is a promising approach, clinical trials to stimulate the immune system of cancer patients were somewhat disappointing. This failure could be due to the fact that large amounts of immunosuppressive mediators such as PGE 2 are secreted into the tumor environment (9, 10) . This may be one of several mechanisms by which tumors evade immune recognition. For example, it is known that PGE 2 has profound suppressive effects in vitro on cellular and humoral immune responses (11) . PGE 2 is also known to down-regulate the generation of IL-2-activated killer cell activity (12) , although its interactions with IL-15 are not known.
IL-15R complex includes a specific ␣-chain (IL-15R␣) that is different from IL-2R␣ (13) . It also uses IL-2R␤ and common ␥-chain (␥ c -chain) 3 that is used by IL-2, IL-4, IL-7, and IL-9 for binding and signaling (4) . We show here that PGE 2 suppressed IL-15-mediated NK cell function and down-regulated surface ␥ cchain expression.
Materials and Methods

Reagents
Fresh buffy coats were obtained from Mississippi Blood Services (Jackson, MS). Anti-CD19-, anti-CD3-, and anti-CD14-coated magnetic beads were purchased from Dynal (Great Lake, NY). Simultest (anti-CD3-FITC and anti-CD16/CD56-PE) and streptavidin-peridinin chlorophyll protein were purchased from Becton Dickinson (San Jose, CA). Biotinylated anti-CD14, anti-CD19-FITC, and PGE 2 were purchased from Sigma (St. Louis, MO). Quantum Simply Cellular microbeads were obtained from Flow Cytometry Standards (San Juan, PR). PE-conjugated anti-IL-2R␤ (Mik␤1) and anti-IL-2R␥ were purchased from PharMingen (San Diego, CA). Human recombinant IL-15, anti-IL-15 Ab, and anti-IL-15R␣ Ab were purchased from R&D Systems (Minneapolis, MN). All primers were obtained from Cruachem (Aston, PA).
(FACScan; Becton Dickinson). NK cells routinely contained Ͻ1% CD3 ϩ (T cells), Ͻ1% CD19 ϩ (B cells), and Ͻ2% CD14 ϩ (monocytes).
Cell cultures
Pure NK cells (2 ϫ 10 5 /well) were cultured in RPMI 1640 with antibiotics and 10% FBS in 96-well U-bottom tissue culture plates with or without different concentrations of rIL-15 and PGE 2 for 1-3 days. The supernatants were harvested and stored at Ϫ80°C for measuring cytokines by ELISA. Cells were harvested and either stained with appropriate Abs for flow cytometric analysis or stored in guanidium isothiocyanate at Ϫ80°C. PGE 2 was dissolved in 95% ethanol and further diluted with RPMI 1640. The final concentration of ethanol had no effect on NK cell function.
ELISA
Concentrations of IFN-␥, IL-4, IL-10, and TGF-␤ 1 were determined by an ELISA using commercially available Ab pairs and recombinant standards (PharMingen or R&D Systems) according to a protocol established in our laboratory (14) . The lower detection limits for these cytokines were as follows: Ͻ10 pg/ml (IL-4), Ͻ10 pg/ml (IL-10), Ͻ25 pg/ml (IFN-␥), and Ͻ200 pg/ml (TGF-␤ 1 ).
NK cytotoxicity assay
Cytotoxicity mediated by NK cells was determined by 51 Cr release assay (15) . Target cells (K-562) were labeled with 100 Ci Na 2 51 CrO 4 for 2 h, washed three times, and adjusted to 2 ϫ 10 5 cells/ml. Serially diluted, activated, purified NK cells were incubated with 51 Cr-labeled K-562 cells at various E:T ratios in a routine 4-h assay. One hundred microliters of supernatant from each well were counted for 51 Cr release using a gamma counter. Spontaneous and maximum release was measured by adding media and 4% Triton X-67, respectively, to target cell wells. The percent lysis was determined as follows: 100 ϫ (experimental release Ϫ spontaneous release)/(maximum release Ϫ spontaneous release).
Flow cytometric detection and quantitation of receptor expression
Results were presented as the percent of positive cells or mean channel fluorescence. Briefly, the flurochrome-conjugated Ab was titered to ensure saturation of Ab binding sites on cells. The number of binding sites per cell was calculated by using Quantum Simply Cellular microbeads (16) , which uses a mixture of beads with different binding capacities for mouse mAbs. These standard beads were run through a flow cytometer each time to establish a calibration curve. Using Quick Cal software (Flow Cytometry Standards, San Juan, Puerto Rico), the binding capacity of the sample cell population was calculated.
RNA extractions, RT-PCR
Total RNA was extracted from pure NK cells using guanidium isothiocyanate method (17) . RNA was reverse transcribed followed by PCR using the following primers: for IL-15R␣, 5Ј-GTCAAGAGCTACAGCTTGTAC-3Ј (forward) and 5Ј-GTGAGCTTTCTCCTGGAG-3Ј(reverse); for ␥ c -chain, 5Ј-GGGAACCCAGGAGACAGG-3Ј (forward) and 5Ј-AGCGGCTC CGAACACGAAAC-3Ј (reverse); and for IL-2R␤, 5Ј-GGCTTTTGGCT TCATCATCT-3Ј (forward) and 5Ј-CTTGTCCCTCTCCAGCACTT-3Ј (reverse). G3PDH was used as a control. PCR products were separated on a 2% agarose gel containing ethidium bromide. For quantitation, PCR bands on the negative film of gel photographs were scanned and density of the bands was calculated using image analysis software.
Statistics
The data were analyzed by Student's t test or ANOVA with Student-Newman-Kuels test for group comparison and were considered statistically significant at a p value of Ͻ0.05.
Results
Suppression of NK cell function by PGE 2
The effect of PGE 2 on cytotoxicity and IFN-␥ production, two important functions of NK cells, was initially assessed. PGE 2 suppressed cytotoxicity of IL-15-activated human NK cells in a dosedependent manner (Fig. 1A) and at different E:T ratios (Fig. 1B) . Suppression of NK-mediated cytotoxicity was observed at 1 ng/ml. However, in the presence of higher (100 -200 ng/ml) amounts, significant suppression was evident.
IFN-␥ production was measured at the secretional level by ELISA and the transcriptional level by RT-PCR. PGE 2 suppressed IFN-␥ production at both the protein ( Fig. 2A ) and the mRNA levels ( Fig. 2B ). In day-2 cultures, average IFN-␥ production was 12,000 pg/ml (Fig. 1A) ; suppression induced by PGE 2 was dose dependent. IFN-␥ secretion was much lower at day 1 (Table I) but increased further in cultures maintained for 5 days, with even greater suppression by PGE 2 (data not shown). At the mRNA level, strong up-regulation of IFN-␥ expression was observed at 2 h after IL-15 treatment; IFN-␥ expression was not affected by PGE 2 . At 18 h, PGE 2 -mediated suppression of IFN-␥ was more evident. No effect of PGE 2 on the viability, as determined by trypan blue exclusion test, was observed. Likewise, in the presence of IL-15, no significant increase in the number of NK cells was evident.
Expression of IL-15R␣ on human NK cells and the effect of PGE 2 on its expression
Surface and mRNA expression of IL-15R␣ on NK cells was also examined. Human NK cells expressed constitutive levels of IL-15R␣ mRNA; an increase was induced by IL-15, which was dose dependent (Fig. 3A) . This increase was evident at 2 h, peaked at 8 h, and remained elevated at 18 h. Anti-IL-15 Ab inhibited the IL-15-mediated increase in IL-15R␣ (see lane 6; Fig. 3A ). As shown in Fig. 3B , the density ratio of IL-15R␣/G3PDH was 1.4 for IL-15-treated (18 h) as compared with 0.4 for nontreated cells. PGE 2 did not significantly suppress the IL-15-mediated up-regulation of IL-15R␣. Flow cytometric analysis of surface IL-15R␣ expression showed that IL-15R␣ was detectable at very low levels and neither IL-15 nor PGE 2 modulated its expression (data not shown). 
Expression of IL-2R␤ and ␥ c -chain on human NK cells and their modulation by IL-15 and PGE 2
After 2 days in culture with or without IL-15 and/or PGE 2 , 2 ϫ 10 6 /ml purified human NK cells were analyzed for the expression of IL-2R␤ or ␥ c -chain by flow cytometry. High levels of surface IL-2R␤ were observed on human NK cells. Both the percent of positive cells and the number of binding sites for IL-2R␤ were significantly less after IL-15 treatment, probably due to internalization; PGE 2 had no effect (Fig. 4, A and B) . In contrast, the percent of positive cells and the number of binding sites for ␥ cchain were increased after IL-15 treatment (Fig. 5, A and B) . When PGE 2 was added to these cultures, a significant decrease in the percent of positive cells and binding sites was observed. Effects of IL-15 and PGE 2 on the expression of surface IL-2R␤ and ␥ c -chain were observed even at days 1 and 3 (Table I) .
Transcriptional levels of IL-2R␤ and ␥ c -chain were also measured by RT-PCR. IL-15 or IL-15 and PGE 2 cotreatment did not significantly affect constitutive expression of ␥ c -chain although a consistent increase in the expression of ␥ c -chain was observed after IL-15 treatment (Fig. 6, lane 5 vs 7) . Similar results were obtained for the expression of IL-2R␤ at the mRNA level (data not shown). Suppression of IL-15-mediated IFN-␥ production or ␥ cchain expression was not due to the endogenous production of IL-4, IL-10, or TGF-␤ 1 by NK cells because neutralizing Abs to these cytokines failed to reverse the suppression (Table II) . These suppressive cytokines were not detected in NK cell culture supernatants at any time (data not shown).
Discussion
NK cells can be stimulated by cytokines such as IL-2, IL-12, IL-15, and IL-18. Upon stimulation, NK cells up-regulate cytolytic capacity and secrete higher levels of IFN-␥ and other cytokines. Because NK activity is suppressed in cancer-bearing hosts, cytokine treatments may offer one approach to restore or boost NK functions. However, clinical trials for cytokine immunotherapy of cancer have had limited success so far. This failure could be due to the fact that high amounts of suppressive factors are present in tumor-microenvironment. A better understanding of functional interactions between tumor-derived suppressive mediators and cytokine-activated NK cells is essential for designing strategies for cytokine based immunotherapy in cancer patients. Along these lines it is known that tumor-derived PGE 2 is one such suppressive mediator that inhibits host immunity and inhibition of PGE 2 production has been shown to increase anti-tumor response (18) . We had recently reported that PGE 2 could be suppressive if present simultaneously with IL-15 in the NK cell cultures (19) . Our results clearly showed that PGE 2 suppressed IL-15-mediated human NK cell function. Both cytotoxicity and IFN-␥ production were suppressed in a dose-dependent manner. PGE 2 is known to inhibit Th 1 cytokine responses and enhance Th 2 responses (20, 21) . It has also been reported that the presence of PGE 2 before or during T cell activation is necessary to exert its inhibitory effect (21) . Because large amounts of PGE 2 are present near tumors, it is important to evaluate NK cell function in the presence of not only cytokines but also PGE 2 . Our data showed that PGE 2 significantly suppressed IFN-␥ production by IL-15-activated NK cells. IFN-␥ production at the transcriptional level was not inhibited at 2 h. However, by 18 h complete inhibition was observed. Most studies have reported suppression of IFN-␥ at the secretional level. Our studies demonstrate that the suppression is also at the mRNA level. The concentration of PGE 2 (200ng/ml) at which strong suppressive effects were seen is comparable with those reported in the literature and is biologically relevant.
There could be several mechanisms by which PGE 2 could have suppressed IL-15-mediated NK function. IL-15 binds to an IL-15R complex, which is composed of a specific subunit IL-15R␣ as well as IL-2R␤ and ␥ c -chain (22, 23) . It is possible that PGE 2 knocks out one or more of these receptor chains. Recently one study reported that PGE 2 inhibited responsiveness of activated human PBMCs and T cells through the suppression of expression of IL-12R␤ 1 (24) . PGE 2 is also known to increase IL-1R (25), downregulate IL-2 (26), and TGF␤R (27) , and release soluble receptors for TNF-␣ (28). However, to our knowledge, no information is available on how PGE 2 may regulate IL-15R on NK cells. Our results showed a strong constitutive expression of IL-15R␣ at the mRNA level but very little surface expression was observed by flow cytometric analysis. IL-15 treatment increased IL-15R␣ mRNA expression in a dose-dependent manner and it was inhibited by anti-IL-15 Ab. This increase in IL-15R␣ mRNA expression was seen as early as 2 h, reached a peak at 8 h, and was still strongly present at 18 h. PGE 2 treatment did not significantly suppress this expression. This is in contrast with the studies that have reported inhibition of cell surface expression of IL-2R␣ and IL-2R␣-specific mRNA after PGE 2 treatment in T lymphocytes (26) . These differences may be due to the cell type (NK vs T) or to differential regulation of different cytokine receptors by PGE 2 . Recently, it was reported that the role of IL-15R␣ in the high affinity IL-15R complex was distinct from the IL-2R␣ in the high affinity IL-2R complex (29) .
The common ␥ c -chain is shared by IL-2, IL-4, IL-7, IL-9, and IL-15R. It is expressed at low levels on the surface of T lymphocytes (30, 31) and on monocytes (32) . Our results clearly showed that the low levels of constitutive surface expression of ␥ c -chain on NK cells were significantly increased after IL-15 stimulation. The constitutive expression of ␥ c -chain mRNA was higher, but not significant, after IL-15 treatment; PGE 2 had no effect on this expression. We have also observed an intracellular expression of ␥ c -chain by flow cytometric analysis that was decreased after 5-8) . NK cells were cultured for 18 h with media (lanes 1 and 5) , 200 ng/ml PGE 2 (lanes 2 and 6), 200ng/ml IL-15 (lanes 3 and 7) , and IL-15 plus PGE 2 (lanes 4 and 8) . a The detection limit of INF-␥ ELISA was 25 pg/ml. NK cells (2 ϫ 10 6 /ml) were cultured for 2 days with or without 200 ng/ml IL-15, 200 ng/ml PGE 2 , 10 g/ml anti-IL-4, 10 g/ml anti-IL-10, or 10 g/ml anti-TGF-␤ 1 . Data from a representative experiment (one of three) are shown.
IL-15 stimulation and this decrease was partially reversed after PGE 2 treatment (data not shown). As reported in recent studies (33) , it appears that ␥ c -chain subunit is stored inside cells and is translocated to the surface after activation. This suggests that after IL-15 activation of human NK cells, intracellularly stored ␥ c -chain was translocated to the surface; PGE 2 may have modulated this translocation resulting in down-regulation of surface ␥ c -chain subunit. Studies have shown that T cells express TCR␤-chains intracellularly, which are transported to the surface after TCR␣-chain is synthesized. Although this and some other similar models are reported (34, 35) , expression of IL-2R␤ and ␥ c -chain on human NK cells is unique especially after IL-15 activation. The surface expression of IL-2R␤ was consistently decreased after IL-15 stimulation whereas expression of ␥ c -chain was significantly increased at the same time. It is possible that there may be some connection in their expression pattern. Down-regulation of IL-2R␤ is probably due to internalization of IL-15/IL-2R␤ complex. Because expression of ␥ c -chain was increased, it is tempting to speculate that these two events are interrelated and internalization of IL-15/IL-2R␤ complex helped translocation of ␥ c -chain subunit to the surface. However, this may not be the mechanism because PGE 2 treatment did not affect expression of IL-2R␤ but ␥ c -chain expression was significantly decreased.
The suppressive cytokines IL-4, IL-10, and TGF-␤ 1 were not detected in the supernatants. In addition, to rule out the suppressive effects of endogenous production of undetectable levels of these cytokines, neutralizing Abs for IL-4, IL-10, or TGF-␤ 1 were added to the cultures; however, they did not reverse the suppression (Table II). Therefore, the suppressive effect of PGE 2 was not due to these cytokines. There are conflicting reports regarding the effect of IL-13 on NK cells. It has been reported previously that the functional IL-13R is not expressed on NK cells (36) and lymphokine-activated killer (37) cells. Some recent studies have shown that although IL-13 suppressed IFN-␥ production in T cell cultures, in primary human NK cell cultures IL-13 induced low levels of IFN-␥ production (38) . Therefore, we did not consider IL-13 as a candidate for the suppressive effect of PGE 2 . It cannot be ruled out at this time that some unknown cytokine secreted in these cultures could have suppressed IL-15-stimulated NK cell function.
Recently, many therapeutic approaches are focused on cytokine receptor subunits and signaling pathways. Clinical trials with Mik␤ 1 Ab directed toward IL-2/15R␤ are being conducted. Other therapeutic efforts include development of an inhibitor of Janus kinase (JAK)3 signaling molecule that is used by IL-2, IL-4, IL-7, IL-9, and IL-15. Because these cytokines share receptors and signaling pathways such as JAK/STAT, more information about their receptor expression patterns and precise roles after activation by cytokines will be useful. It is possible that different cytokines may use different receptor subunits for internalization and, therefore, an Ab directed toward a particular receptor subunit may differentially block the stimulation by cytokines that use a common receptor subunit. In summary, results of this study revealed regulation of IL-15R expression by IL-15 and PGE 2 in human NK cells. In particular, our data on down-regulation of ␥ c -chain on human NK cells by PGE 2 is interesting because the importance of ␥ c -chain in immune activation is known. For example, mutation of ␥ c -chain protein in mice and humans results in X-linked severe combined immunodeficiency, which is characterized by impaired development of T cells, B cells, and NK cells (39) . Furthermore, a defect in ␥ c -chain expression leads to impaired activation of JAK3/ STAT5 pathway. Studies are in progress to investigate signal transduction molecules that may be affected by PGE 2 .
